c

e-learning | Sotagliflozin with insulin for type 1 diabetes

2nd June 2020 by Louise Hudman

e-learning | Sotagliflozin with insulin for type 1 diabetes

This is a new guideline from NICE published in Feb 2020 advising that sotagliflozin can be used alongside insulin for type 1 diabetes.

Sotagliflozin is an SGLT1 and SGLT2 inhibitor. It is only licensed for type 1 diabetes, not for type 2 diabetes.

Dapagliflozin was endorsed by NICE in Aug 19 as a treatment for type 1 diabetes. Sotagliflozin has exactly the same restrictions on its use. It improves HbA1c, brings greater weight loss and improves quality of life. It is presumed that this drop in HbA1c will lead to a lower risk of complications from diabetes, though this hasn’t yet been shown.

Read more

No credit card details needed – it takes two minutes.

Join free trial

Login

Already a member? Login to view this content.

Login

"I have already managed to get some locum sessions via LocumDeck and I have now been generating invoices with ease by using the online system. It has been amazing! It is great to have all your paperwork in one place and this makes life easier for the practices as well as for yourself."

Dr Gisha Mathew, GP

See the full list of features within our NASGP membership plans

Membership